CARDIOVASCULAR SYSTEM .
##semicolon##
cardiovascular , heart , blood vessels , coronary , arterial disease. Introduction##article.abstract##
The cardiovascular system consists of the heart and blood vessels.[1] There is a wide array of problems that may arise within the cardiovascular system, for example, endocarditis, rheumatic heart disease, abnormalities in the conduction system, among others, cardiovascular disease (CVD) or heart disease refer to the following 4 entities that are the focus of this article. Coronary artery disease (CAD): Sometimes referred to as Coronary Heart Disease (CHD), results from decreased myocardial perfusion that causes angina, myocardial infarction (MI), and/or heart failure.
##submission.citations##
1.Farley A, McLafferty E, Hendry C. The cardiovascular system. 2012 Oct 31-Nov
6Nurs Stand. 27(9):35-9. [PubMed]
2.Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S,
Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M,
Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH,
Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita
K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK,
Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA,
Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ,
Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P., American Heart Association
Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics
Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report From the
American Heart Association. Circulation. 2018 Mar 20;137(12):e67-e492. [PubMed] 3.US Preventive Services Task Force. Curry SJ, Krist AH, Owens DK, Barry MJ,
Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M,
Landefeld CS, Mangione CM, Silverstein M, Simon MA, Tseng CW, Wong JB. Risk
Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US
Preventive Services Task Force Recommendation Statement. JAMA. 2018 Jul
17;320(3):272-280. [PubMed]
4.Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB, Wilson PW, Savage
PJ. Trends in cardiovascular complications of diabetes. JAMA. 2004 Nov
24;292(20):2495-9. [PubMed]
5.Vasan RS, Sullivan LM, Wilson PW, Sempos CT, Sundström J, Kannel WB, Levy
D, D'Agostino RB. Relative importance of borderline and elevated levels of coronary
heart disease risk factors. Ann Intern Med. 2005 Mar 15;142(6):393-402. [PubMed]
6.Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A,
Pais P, Varigos J, Lisheng L., INTERHEART Study Investigators. Effect of potentially
modifiable risk factors associated with myocardial infarction in 52 countries (the
INTERHEART study): case-control study. Lancet. 2004 Sep 11-17;364(9438):937-52.
[PubMed]
7.Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB. Lifetime
risk of cardiovascular disease among individuals with and without diabetes stratified
by obesity status in the Framingham heart study. Diabetes Care. 2008 Aug;31(8):1582
4. [PMC free article] [PubMed]
8.Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L,
Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM,
Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW,
Rosamond WD., American Heart Association Strategic Planning Task Force and
Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact
Goal through 2020 and beyond. Circulation. 2010 Feb 02;121(4):586-613. [PubMed]
9.Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E,
Hlatky MA, Hodgson JM, Kushner FG, Lauer MS, Shaw LJ, Smith SC, Taylor AJ,
Weintraub WS, Wenger NK, Jacobs AK, Smith SC, Anderson JL, Albert N, Buller CE,
Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG,
Nishimura R, Ohman EM, Page RL, Stevenson WG, Tarkington LG, Yancy CW.,
American College of Cardiology Foundation. American Heart Association. 2010
ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a
report of the American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103.
[PubMed]
10.Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R,
Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero
ST, Smith SC, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson
JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman
JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli
GF., American College of Cardiology/American Heart Association Task Force on
Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular
risk: a report of the American College of Cardiology/American Heart Association Task
Force on Practice Guidelines. Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73.
[PubMed]
424
